Julius Knowles Keros Therapeutics, Inc. (KROS) insider trading activity

KROS Quotes by TradingView

Julius Knowles is of Keros Therapeutics, Inc.. Currently has a direct ownership of 6,441 shares of KROS, which is worth approximately $88,821. The most recent transaction as insider was on Jun 04, 2025, when has been sold 5,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.44K
440.81% 3M change
440.81% 12M change
Total Value Held $88,821

Julius Knowles Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2025
BUY
Grant, award, or other acquisition
-
5,250 Added 44.91%
6,441 Common Stock
Apr 13 2020
BUY
Open market or private purchase
$24,987 $20.98 p/Share
1,191 Added 50.0%
1,191 Common Stock
JK

Julius Knowles

Lexington, MA

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS